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 1 
Do interventions containing risk messages increase risk appraisal and the subsequent 2 
vaccination intentions and uptake?: A systematic review and meta-analysis 3 
 4 
Abstract 5 
Purpose: There is good evidence that for many behaviours, increasing risk appraisal can lead 6 
to a change in behaviour, heightened when efficacy appraisals are also increased. The present 7 
systematic review addressed whether interventions presenting a risk message, increase risk 8 
appraisal and an increase in vaccination intentions and uptake.  9 
Method: A systematic search identified Randomised Controlled Trials of interventions 10 
presenting a risk message and measuring risk appraisal and intentions and uptake post-11 
intervention. Random effects meta-analyses investigated the size of the effect that 12 
interventions had on vaccination risk appraisal, and on vaccination behaviour or intention to 13 
vaccinate, and the size of the relationship between vaccination risk appraisal and vaccination 14 
intentions and uptake.  15 
Results: Eighteen studies were included and 16 meta-analysed. Interventions overall had 16 
small significant effects on risk appraisal (d= 0.161, p= .047) and perceptions of 17 
susceptibility (d= 0.195, p= .025), but no effect on perceptions of severity (d= -0.036, p= 18 
.828). Interventions showed no effect on intention to vaccinate (d= 0.138, p= .195) and no 19 
effect on vaccination behaviour (d= 0.043, p= .826). Interventions typically did not include 20 
many Behaviour Change Techniques (BCTs), with the most common BCT unique to 21 
intervention conditions being ‘Information about Health Consequences’. Few of the included 22 
studies attempted to, or successfully increased, efficacy appraisals.  23 
Conclusions: Overall, there is a lack of good quality primary studies, and 24 
existing interventions are suboptimal. The inclusion of additional BCTs, including those to 25 
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target efficacy appraisals, could increase intervention effectiveness. Protocol 26 
(CRD42015029365) available from http://www.crd.york.ac.uk/PROSPERO/ 27 
Keywords; Vaccination, Randomised Controlled Trial, Uptake, Risk Appraisal 28 
 29 
 30 
Many infectious diseases are preventable through vaccination. Vaccinations are responsible 31 
for preventing two to three million deaths per year globally (WHO, 2016). The efficacy of 32 
vaccination can be demonstrated by the eradication of Smallpox worldwide over the last 40 33 
years (Miller & Sentx 2006). Furthermore, in the UK, vaccination has led to a 99% reduction 34 
in Meningitis C cases in those under 20 years old since its introduction in 1999 (NHS 35 
Choices 2016). 36 
  37 
Despite benefits to health at the individual and societal levels, uptake of vaccination 38 
does not reach targets set by the World Health Organisation (WHO). It is estimated that 18.7 39 
million children worldwide do not receive the recommended, routine vaccinations against 40 
preventable diseases (WHO, 2016). In developed countries, programmes routinely include 41 
vaccination of major childhood illnesses and vaccination against seasonal illnesses for groups 42 
at higher risk. In the UK, although free routine vaccinations are available for groups at higher 43 
risk, national uptake targets of these vaccinations are not met (WHO, 2016). Uptake levels of 44 
some vaccinations remain poor, e.g. only 45.1% of adults under 65 years in a clinical risk 45 
group (i.e. those that are considered to be more at risk of the illness being vaccinated 46 
against,excluding pregnancy) in the UK received the flu vaccination in the 2015- 16 season. 47 
(www.gov.uk).  48 
 49 
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Individual factors contribute to vaccination decisions, notably risk appraisal, defined 50 
as individuals’ beliefs about personal susceptibility associated with a disease and the severity 51 
of that disease (Wright, 2010). In a recent systematic review, vaccination uptake was lower 52 
amongst people who believed that they were unlikely to contract the disease, or those that 53 
believed that the disease was not severe (Bish, Yardley, Nicoll & Michie, 2011). Vaccination 54 
uptake was also lower when individuals believed that the vaccine was ineffective. 55 
 56 
There is now good systematic review evidence that increasing risk appraisal can have 57 
a small effect on increasing behaviour, and that interventions increasing risk appraisal have a 58 
greater effect on intention when elements of efficacy appraisals (comprised of self-efficacy  59 
and response-efficacy) are simultaneously increased (Peters, Ruiter & Kok, 2013; Sheeran, 60 
Harris & Epton, 2014; Tannenbaum, Hepler, Zimmerman, Saul, Jacobs, Wilson, et al 2015). 61 
In line with this, one way of increasing vaccination uptake would therefore be to increase 62 
individuals’ beliefs about the risk of infectious diseases, and the efficacy of vaccinations in 63 
reducing that risk.   64 
 65 
Existing meta-analyses of experimental studies examining the effect of changing risk 66 
appraisals on behaviour, have typically examined effects across a number of health-related 67 
behaviours (Sheeran et al, 2014, Tannenbaum et al, 2015). This approach increases the 68 
number of studies analysed, and thereby increases the strength of confidence in the effect size 69 
reported. By contrast, studies examining only one behaviour are considered more informative 70 
for developing future interventions, as estimates of effect can be reliably attributable to the 71 
one behaviour (Wright, 2010). In line with this, the systematic review of Brewer, Chapman, 72 
Gibbons, Gerrard, McCaul, & Weinstein (2007) included only studies of vaccination. This 73 
review however included cross-sectional and prospective studies, which are not as 74 
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informative for intervention design as experimental designs, as correlation alone does not 75 
allow causal relationships to necessarily be inferred (Weinstein, Rothman & Nicolich, 1998). 76 
 77 
A further meta-analysis by Sheeran and colleagues (2014) examined the effect of 78 
heightening risk appraisal on intentions and behaviour. The overall effect (intention; d= 0.31, 79 
behaviour; d= 0.23), and the effect by behaviour type (including for vaccination: intention; 80 
d= 0.38, behaviour; d= 0.33), was reported. This meta-analysis however only included 81 
Randomised Controlled Trials that were successful in changing risk appraisals; if there was 82 
no change in risk appraisals, then they were not included in the review. This decision was 83 
taken by the authors because they specifically wanted to examine the relationship between 84 
risk and behaviour, necessitating that only studies where the manipulation of risk was 85 
successful be included. This however means that the success of existing interventions  in 86 
changing risk appraisals cannot be inferred from the findings.    87 
 88 
The primary aim of the present systematic review was to examine interventions 89 
reported in the literature to see whether those that include risk messages have been successful 90 
in influencing risk appraisals and the subsequent intentions and uptake of vaccination. To 91 
further add to the body of evidence about the relationship between risk appraisal and 92 
vaccination uptake, secondary aims of the current systematic review were to examine the size 93 
of the relationship between these variables, and also to examine whether changes to risk 94 
appraisal are enhanced by experimentally induced increases in efficacy appraisal. It is the 95 
first systematic review to examine if risk messages influence risk appraisal and vaccination 96 
using only experimental studies. This will enable firmer conclusions to be drawn about 97 
success of existing intervention strategies in changing risk and subsequent vaccination 98 
behaviour. The present systematic review also aimed to establish which BCTs were present in 99 
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interventions used to increase risk appraisal and vaccination intention and uptake in the 100 
included studies, and how these were associated with changes in risk appraisal and 101 
vaccination intention and uptake.  102 
  103 
Method 104 
This systematic review was conducted in accordance with the protocol (CRD42015029365) 105 
published on the International Prospective Register of Systematic Reviews (PROSPERO). 106 
http://www.crd.york.ac.uk/PROSPERO/ 107 
 108 
Inclusion and Exclusion Criteria 109 
Studies were required to be randomised controlled trials, with random assignment of 110 
participants to experimental conditions. At least one control condition was required; this 111 
could have been either no intervention or usual practice.  No date restrictions or limitations 112 
on country of study were set but studies had to have been published in the English language.  113 
 114 
Studies were included in the systematic review if they described an intervention 115 
aiming to increase vaccination intention or uptake that included a risk message. Whether an 116 
intervention had targeted an increase in risk appraisal was determined by whether this 117 
construct (namely susceptibility and/or severity) was measured and reported post-118 
intervention. Studies were also required to have measured vaccination uptake, or intention to 119 
have a vaccination, at least once following the intervention, where vaccination was the 120 
participant’s own decision, not a decision made on the behalf of someone else e.g. a child.  121 
 122 
To be included, studies had to include all of the necessary statistical information to 123 
calculate an effect size for changes in risk appraisal and vaccination intention or behaviour 124 
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following the intervention. Where this information was not available, attempts were made to 125 
contact authors for appropriate data. If this was unsuccessful, then the study was included in 126 
the systematic review, but excluded from the meta-analysis. Studies included in the 127 
systematic review were required to provide a description of the intervention (which could be 128 
any type or length of exposure). Where there was no description, or the information provided 129 
was not sufficiently reported, then attempts were made to contact authors for this 130 
information. In cases where no further intervention information was available, the available 131 
information was coded. Where no information on the intervention was available, the study 132 
was excluded from the systematic review. 133 
 134 
Search Strategy 135 
Peer-reviewed publications were searched using CINAHL, Medline, PsycINFO, Scopus 136 
(including Science Direct) and Web of Science. Reference sections of included papers were 137 
examined to identify any relevant studies that were not identified by the initial search. 138 
Forward citation searches were conducted on included articles and major systematic reviews 139 
in this area (namely Brewer, Chapman, Gibbons, Gerrard, McCaul, & Weinstein, 2007; 140 
Sheeran, Harris & Epton, 2014; Tannenbaum, Hepler, Zimmerman, Saul, Jacobs, Wilson & 141 
Albarracín, 2015). Last searches were completed in September 2017. Full search terms can be 142 
found in the online supplemental materials (supplemental material 1). 143 
 144 
To identify unpublished studies the Ethos database was used to search for relevant 145 
PhD theses using combinations of the same search terms. Additionally, authors of included 146 
studies were contacted to identify any other unpublished, relevant studies (contact details for 147 
authors of eight studies were available, and of those, three responses were received).  148 
Furthermore, requests were distributed electronically via affiliated groups (namely European 149 
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Association of Social Psychology, European Health Psychology Society, Midlands Health 150 
Psychology Network, Social, Personality and Health Network and Society for Personality and 151 
Social Psychology) asking members if they were aware of any unpublished papers meeting 152 
the inclusion criteria. 153 
 154 
Screening 155 
Titles and abstracts of papers identified from database searches were initially screened by the 156 
lead author. A second stage of screening was undertaken using the full text of all studies that 157 
had not yet been excluded. This led to a sample of studies which met all inclusion criteria and 158 
which would provisionally be included in the meta-analysis (see Figure 1). All studies 159 
considered eligible for inclusion, including any studies where inclusion was not clear, or 160 
where queries arose, were examined by the second author. A small number of minor 161 
discrepancies were resolved by discussion and a consensus reached on included studies.  162 
Figure 1 here.  163 
Extraction and Coding 164 
Information required for the calculation effect sizes was extracted. In all studies except one 165 
(Prati Pietrantoni and Zani 2012), outcome data for susceptibility or severity or both was 166 
reported separately. In the study by Prati and colleagues (2012) a combined risk outcome 167 
measure was reported. All of this information was extracted. In addition, information was 168 
extracted for vaccination behaviour and intention to vaccinate. In studies that used multiple 169 
follow-up measures, the first measure of risk and intention following intervention, and the 170 
last measure of behaviour reported, was used.  171 
 172 
A number of study and sample characteristics were coded including: the illness type 173 
under examination, whether participants were pregnant, and the age group of participants. 174 
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Whether interventions had successfully increased efficacy appraisals was also extracted. 175 
Please note, whilst it was originally planned that analysis would differentiate between 176 
increases in self and response-efficacy, this was not possible. Of the three studies that 177 
successfully manipulated efficacy appraisals, only two measured self-efficacy, and the other 178 
measured response and self-efficacy as a combined measure. For this reason efficacy 179 
appraisals were analysed as a combined measure. Age group was categorised as follows: 180 
Adolescent: 16-18, Adults: 19-64 and Older Adults: 65+. In cases where the age groups of 181 
participants in any one study crossed these boundaries, the age group was deemed to fall into 182 
the category where the majority of the participants resided). The nature of questions used to 183 
measure risk was also extracted to identify whether conditional or unconditional questions 184 
were used. Conditional questions refer to the likelihood of the event occurring according to 185 
whether action is taken to prevent it. Unconditional questions on the other hand refer to the 186 
likelihood of the event occurring regardless of action, and take into account any subjective 187 
factors that influence the individual (Van Der Velde, Hooykaas & Van Der Pligt, 1996). 188 
Unconditional questions have been described as being methodologically inferior because they 189 
allow for the behavioural intentions of participants to influence risk appraisals (Weinstein, 190 
Rothman, & Nicolich, 1998). 191 
 192 
Coding of BCTs within interventions was completed using the 93-item Behaviour 193 
Change Technique Taxonomy v1 (Michie, Richardson, Johnston, Abraham, Francis, 194 
Hardeman, Eccles, Cane & Wood, 2013). Full interventions were coded where available, 195 
with authors being contacted for full interventions when these were not present within the 196 
paper. When no further information was provided, descriptions within the papers were coded. 197 
BCTs within both experimental and control group interventions were coded. Any BCTs that 198 
were present in both of the conditions were excluded to ensure that only unique intervention 199 
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content was isolated. BCT coding was completed independently by both the lead author (who 200 
has previous experience in coding behaviour change techniques), and the second author (who 201 
has more extensive behaviour change technique coding experience). Any disagreements were 202 
discussed and a consensus was reached where required.  203 
 204 
In addition, the lead author coded: the dose of each BCT (dose was derived from 205 
information available within intervention descriptions and was calculated by counting the 206 
number of times the BCT was delivered, either using the same intervention strategy or a 207 
something different), practical applications (Bartholemew, 2016) used to deliver each BCT, 208 
and the mode of intervention delivery (in line with the Mode of Delivery of Behaviour 209 
Change Interventions Taxonomy version 0; Carey, Evans, Horan, Johnston, West and Michie 210 
2016). Categorised modes included: printed material (‘Delivery through information 211 
produced on paper; can be hand-delivered or posted to the participant; materials can include 212 
diagrams, pictures and text.’), Digital; Computer/Television (‘Delivery through a computing 213 
device or television set’), and Human; face-to-face (‘Delivery through human contact in 214 
which the participant meets a person in real-time, face-to-face’). See supplemental material 2. 215 
 216 
Assessment of Study Risk of Bias 217 
A risk of bias assessment is designed to assess the validity of included studies, and to 218 
examine whether any bias exists (whereby the true effect of the intervention is overestimated 219 
or underestimated). The Cochrane Risk of Bias Tool was used to assess the risk of bias in the 220 
included studies, and to assess the quality of the randomised controlled trials (Higgins & 221 
Green, 2011). Risk of bias assessment was completed by the lead author, and independently 222 
assessed by a second coder. Any disagreements in scoring were discussed and a consensus 223 
was reached. 224 
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 225 
Publication Bias (the tendency for studies reporting significant or positive findings to 226 
be published more commonly than those without statistical significant findings, leading to 227 
meta-analyses missing some studies) was assessed using Funnel Plots and Trim and Fill 228 
analysis conducted in line with Duval and Tweedie (2000).  229 
 230 
Statistical Methods 231 
Meta-analysis software Comprehensive Meta-Analysis (CMA) version 3 was used to 232 
calculate Standardised Mean Difference for each intervention using a Random Effects model. 233 
Where separate outcome measures for risk were provided (i.e. susceptibility and severity), 234 
these were entered separately into CMA and their mean used within effect size calculations. 235 
A pooled and weighted Standardised Mean Difference was thus calculated for risk 236 
(susceptibility and severity combined), intention to vaccinate, and behaviour (having the 237 
vaccination). Effect size estimates were however also calculated separately for measures of 238 
susceptibility and severity where studies provided the necessary information. Where studies 239 
included multiple interventions containing different types of risk messages, all of these 240 
interventions were included separately and the sample size of the control group was reduced 241 
to control for multiple comparisons. The relationship between risk appraisal and vaccination 242 
intention was assessed using a pooled, within-study Pearson Correlation Coefficient. It was 243 
originally planned that the relationship between risk appraisal and vaccination uptake, and 244 
between risk appraisal and intention to vaccinate, would be examined. There were however 245 
insufficient studies reporting the relationship between risk appraisal and behaviour for the 246 
effects to be pooled. For this reason, only the relationship between risk appraisal and 247 
intention to vaccinate is reported. The heterogeneity of the results was calculated using the I² 248 
statistic (Higgin, Thompson, Deeks & Altman, 2003).  249 
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 250 
A number of pre-specified meta regression analyses were conducted. Moderators 251 
were only tested when they contained a sufficient range of values, that is, they had to be 252 
present or absent in at least three studies. Between groups heterogeneity was assessed using 253 
the Q statistic to determine which moderators accounted for significantly different effect size 254 
estimates. Meta regression analysis was conducted to establish whether effect sizes for risk 255 
differed as a function of: whether efficacy appraisal was also increased and whether 256 
conditional or unconditional questions of risk were used. Additionally, they were conducted 257 
to establish whether effect sizes for risk appraisal or vaccination intention or uptake differed 258 
as a function of: the illness being vaccinated against, the age group of participants, and 259 
whether study participants were pregnant or not.  260 
 261 
 A further pre-specified meta regression analysis was also conducted to explore 262 
whether there was a difference in the size of effect (risk, intention, and behaviour) as a 263 
function of BCTs most commonly coded within the included interventions: Information about 264 
Health Consequences, Information about Social and Environmental Consequences or 265 
Credible Source.  266 
 267 
Two further meta regression analyses were performed that were not pre-specified in 268 
the review protocol. These established whether there was a difference in the size of effect 269 
when more than two BCTs were included in the intervention, and according to the mode of 270 
delivery employed.  271 
 272 
Moderators were only tested when they were present or absent in at least three 273 
studies. Accordingly, meta-regression was not conducted for the following moderators: 274 
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credible source for the outcome variable risk, and, credible source and number of BCTs for 275 
the outcome variable intention to vaccinate. No moderators were run for the outcome variable 276 
behaviour. The limited number of studies measuring behaviour meant that there were always 277 
too few studies with the moderator either present or absent..  278 
 279 
Results 280 
Of 10,379 potential studies initially identified (after duplicates were removed), 18 satisfied all 281 
inclusion criteria. A table listing all included studies and summary characteristics can be 282 
found in the online supplemental materials (supplemental material 3). The majority of studies 283 
had a high percentage of female participants, with six studies involving female participants 284 
only, in part attributable to the nature of some studies examining vaccination intention or 285 
uptake in pregnancy. Only three studies recruited only men. Nine of the 18 included studies 286 
reported the mean age of participants, or the age range of participants, as being under 26 287 
years. Seventeen of the 18 included studies were conducted in community settings. 288 
Community settings included participant’s own homes, health centres and churches. The 289 
remaining study (Gerend and Sheperd 2012) was conducted in a laboratory within a 290 
university. Four studies used conditional risk questions, whereas 14 used unconditional risk 291 
questions (an example of a conditional risk question used is ‘What is the likelihood that you 292 
will get the flu this year if you don't get a flu shot?' (Prati et al 2012)).  293 
Table 1 here 294 
Results of Main Outcomes 295 
On the whole, studies reported a statistically significant increase in risk appraisal following 296 
intervention. Of the 18 included studies, thirteen did not measure or manipulate efficacy 297 
appraisals. Of the five that did attempt to manipulate efficacy appraisals, three showed a 298 
statistically significant increase. Thirteen of the included studies measured intention as the 299 
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primary outcome variable, whilst five studies measured behaviour as the primary outcome 300 
variable. Thirteen studies reported a statistically significant increase in vaccination uptake or 301 
intention to vaccinate post intervention. Five reported no increase in intention or uptake as a 302 
result of the intervention.  303 
 304 
Meta-analysis. Sixteen studies, reporting on the effect of 29 interventions, were able 305 
to be included in the meta-analysis (Bennett, Patel, Carlos, Zochowski, Pennewell, Chi & 306 
Dalton, 2015, and Dabbs and Leventhal 1966 contained insufficient statistical information to 307 
be included in the meta-analysis). A full table of effect sizes can be found in Supplemental 308 
material 4.  309 
 310 
Study interventions had a small but significant pooled effect on risk appraisal (d= 311 
0.161, CI 95% .002 to .320, n= 7,914, k= 29, p= .047, I² = 76.855).  By contrast, there was no 312 
significant pooled effect on intention (d= 0.138, CI 95% -.071 to .346, n= 5,905, k= 19, p = 313 
.195, I²= 72.613), or on behaviour (d= 0.043, CI 95% -.343 to .429, n= 2009, k=9, p= .826, 314 
I²= 79.468).  Interventions had a small significant pooled effect on susceptibility (d= 0.195, 315 
CI 95% .024 to .366, n= 6722, k= 27 , p= .025)  but no pooled effect on severity (d= -0.036, 316 
CI 95% -.366 to .293, n= 5390, k= 15, p= .828). There was a small significant relationship 317 
(r= .114, CI 95% = .031 to .196, n= 1017  k= 8, p= .007, I²= 80.303) between risk appraisals 318 
and intention to vaccinate. Six studies reported this relationship, consisting of eight 319 
interventions. Forest plots for risk, intention, behaviour, susceptibility, severity, and the 320 
relationship between risk and intention can be found in the online supplemental materials 321 
(supplemental material 5). 322 
 323 
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The most common BCT, unique to the intervention condition, was ‘Information about 324 
Health Consequences’ which was included in interventions reported by thirteen of the 325 
included interventions. Other BCTs included Credible Source (k= 5), and Information about 326 
Social and Environmental Consequences (k= 6). On the whole, there were very few unique 327 
BCTs used within interventions compared to controls. Three studies had no unique BCTs in 328 
the intervention condition compared to the control condition (de Wit, Das and Vet 2008; 329 
Frew, Owens, Saint-Victor, Benedict, Zhang & Omer, 2014 and Godinho, Yardley, Marcu, 330 
Mowbray, Beard and Michie 2016).   331 
 332 
Study Risk of Bias 333 
Of the 18 studies included in the review, three had a moderate risk of bias (Bennett et al, 334 
2015, Hopfer, 2009 and Vet, de Wit and Das 2011), and 15 had a high risk of bias (Higgins & 335 
Green, 2011). Plots of the risk of bias assessment per domain, and by study can be found in 336 
the online supplemental material (supplemental material 6). The domain contributing most 337 
frequently to an overall high risk of bias rating was ‘Random Sequence Generation’ (unclear 338 
descriptions of how participants were randomised to conditions was often not specified, 339 
resulting in a rating of ‘unclear’) and ‘Selective Reporting (Protocols were often unavailable 340 
or not mentioned, so there was insufficient information to establish whether all of the 341 
intended outcomes had been reported).  342 
 343 
Assessment of Heterogeneity 344 
Considerable heterogeneity was present in measures of risk appraisal I² = 76.855, Intention 345 
I²= 72.613 and Behaviour I²= 79.468. As substantial heterogeneity was present, a random 346 
effects model was used.  347 
 348 
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Publication Bias 349 
There was evidence of Publication Bias for the outcome variable Behaviour. Trim and Fill 350 
analysis made two adjustments, and no change in behaviour was observed. (Adjusted values 351 
can be found in supplemental material 7). There was no evidence of Publication Bias for the 352 
outcomes of risk or Intention and therefore no adjustments were made. 353 
 354 
Meta Regression Results 355 
 All meta-regression results can be found in table 2.  356 
Table 2 here. 357 
 Efficacy Appraisals. Efficacy appraisals had no significant association with risk 358 
(∆d= 0.242, Q= 0.92, p= .339). Interventions that included efficacy had a higher effect size 359 
(d= 0.372, k= 3) than interventions that did not (d= 0.130, k= 14). 360 
 361 
 Type of Risk Question Used. The type of risk question used (conditional or 362 
unconditional) had no significant association with risk (∆d= -0.218, Q= 1.61, p= .205). 363 
Interventions that used unconditional questions had a higher effect on risk (d= 0.237, k= 12) 364 
than interventions that used conditional questions (d= 0.019, k= 4). 365 
 366 
 Illness type: Flu. Illness type had no significant association with risk when flu was 367 
the illness being vaccinated against (∆d= -0,122, Q= 0.57, p= 452). Interventions for flu 368 
vaccination had a higher effect on risk (d= 0.228, k= 9) than when interventions were for 369 
other illnesses (d= 0.106, k= 8).  370 
 Illness type had no significant association with intention when flu was the illness 371 
being vaccinated against (∆d= 0.034, Q= 0.02, p= .876). Interventions for flu vaccination had 372 
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a higher effect on risk (d= 0.152, k= 8) than when interventions were for other illnesses (d= 373 
0.117, k= 4). 374 
 HPV. Illness type had no significant association with risk  when HPV was the illness 375 
being vaccinated against (∆d= 0.139, Q= 0.45, p= .500). Interventions for HPV vaccination 376 
had a lower effect on risk (d= 0.049, k= 3) then when interventions were for other illnesses 377 
(d= 0.188, k= 13). 378 
 379 
 Age Group: Adult. Age Group of participants had no significant association with 380 
risk when participants were Adults (∆d= -0.239, Q= 1.92, p= 0.166). Interventions had a 381 
higher effect on risk when participants were adult (d= 0.250, k= 10) than when they were 382 
other age groups (d= 0.011, k= 6). 383 
 Age group of participants had no significant association with intention when 384 
participants were Adult (∆d= 0.078, Q= 0.10, p= .751). Interventions had a lower effect on 385 
intention when participants were adults (d= 0.112, k= 80 than when they were other age 386 
groups (d= 0.190, k= 4). 387 
Older Adult. Age group of participants had no significant association with risk when 388 
participants were older adults (∆d= 0.245, Q= 1.94, p= .163). Interventions had a higher 389 
effect on risk when participants were other age groups (d= 0.244, k= 11) than when they were 390 
older adults (d= -0.000, k= 5). 391 
 392 
Pregnancy. Whether participants were pregnant had no significant association with 393 
risk (∆d= 0.269, Q= 1.19, p= .276). Interventions had a higher effect on risk when 394 
participants were pregnant (d= 0.396, k= 3) than when they were not pregnant (d= 0.127, k= 395 
13). 396 
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Whether participants were pregnant had no significant association with intention (∆d= 397 
-0.110, Q= 0.14, p= .704). Interventions had a lower effect on intention when participants 398 
were pregnant (d= 0.045, k= 3) than when they were not pregnant (d= 0.155, k= 9). 399 
 400 
BCTs: Information about Health Consequences. Including the BCT information 401 
about health consequences had no significant association with risk (∆d= -0.238, Q= 2.02, p= 402 
.155). Interventions that included Information about Health Consequences had a lower effect 403 
on risk (d= 0.033, k= 6) than interventions that did not 9d= 0.271, k= 10).  404 
Including the BCT Information about Health Consequences had no significant 405 
association with intention (∆d=-0.007, Q= 0.00, p= .970). Interventions that included 406 
Information about Health Consequences had a lower effect on intention (d= 0.128, k= 40 than 407 
interventions that did not (d= 0.135, k= 8). 408 
Information about Social and Environmental Consequences. Including the BCT 409 
information about social and environmental consequences had a small, significant negative 410 
association with risk (∆d= -0.431, Q=4.58, p=.032*). Interventions with this BCT had a 411 
lower effect size (d= -0.179, k= 3) than interventions without this BCT (d=0.252, k=13). 412 
Number of BCTs in intervention (less than two, or two or more). The number of 413 
BCTs had a significant negative association with risk (∆d= -0.431, Q= 8.25, p=.0004**).  414 
Interventions with less than two BCTs had a higher effect size (d=0.344, k=10) than 415 
interventions with two or more BCTs (d=-0.088, k= 6).  416 
  417 
Mode of Delivery: Digital. Digital methods of delivery had no significant association 418 
with risk (∆d= -0.201, Q= 1.54, p= .215). Interventions that used a digital mode of delivery 419 
had a higher effect on risk (d= 0.243, k= 8) than other modes of delivery (d= 0.042, k= 8). 420 
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Digital methods of delivery had no significant association with intention (∆d= 0.052, 421 
Q= 0.01, p= .913). Interventions that used a digital mode of delivery had a lower effect on 422 
intention (d= 0.126, k= 6) than other modes of delivery (d= 0.151, k= 6). 423 
Human. The mode of delivery had a small significant association with risk (∆d= 424 
0.514, Q= 7.21, p= .007**). Interventions delivered by humans had a significantly larger 425 
negative effect on risk (d= -0.252, k= 3) compared to those where other methods of delivery 426 
were used (d= 0.262, k= 13).  427 
Printed Material. Printed materials had no significant association with risk (∆d= -428 
0.201, Q= 0.98, p= .323). Interventions that used printed materials had a higher effect on risk 429 
(d= 0.319, k= 5) than other modes of delivery (d= 0.118, k= 11). 430 
 431 
Where sub-groups within a moderator contained insufficient studies (e.g. for illness 432 
type within studies measuring intention, there were only two studies that examined Hepatitis 433 
B and two that examined HPV), but there was at least one reference group with three or more 434 
studies (e.g. flu had eight studies), the other sub-groups were combined (e.g. Hepatitis and 435 
HPV combined to create an ‘other illness category’) and compared to the reference group 436 
(e.g. flu).  437 
 438 
Discussion 439 
Principal Findings 440 
Overall, whilst interventions containing risk messages did not increase intention to vaccinate 441 
or vaccination behaviour, they did have a small effect on risk appraisal. There was a small 442 
relationship between vaccination risk appraisal and intention to vaccinate. There was a small 443 
but significant pooled effect of interventions on susceptibility, but no pooled effect on 444 
severity. Interventions with higher numbers of BCTs and those delivered in person (as 445 
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opposed to via digital or printed material) had smaller effects on risk appraisals. The majority 446 
of studies had high risk of bias, often due to multiple indicators being unclear.  447 
 448 
Interventions in the present review were found to include few Behaviour Change 449 
Techniques (BCTs), with the most commonly used being Information about Consequences, 450 
Credible Source and Information about Social and Environmental Consequences. The 451 
presence of Information about Social and Environmental Consequences had a negative effect 452 
on vaccination risk appraisal, suggesting that the presence of this BCT within interventions 453 
reduced individuals’ appraisals of risk. Interestingly, of the three studies that included this 454 
BCT, only one successfully increased efficacy appraisal. It is possible therefore that this 455 
finding reflects an element of defensive processing (see Wright, 2010). In other words, 456 
intervention content that triggers individuals to appraise the risk of illness without also 457 
ensuring that they feel able to perform a behaviour perceived as effective, may lead them to 458 
adopt coping strategies such as denial or avoidance.  459 
 460 
Meta regression analysis showed that the number of BCTs included in an intervention 461 
had a small, significant negative effect on risk. Specifically, interventions that had three or 462 
more unique BCTs decreased risk appraisal. This unexpected finding is in contrast to other 463 
reviews which have found that including more BCTs has a greater effect on behaviour change 464 
(Craddock, ÓLaighin, Finucane, Gainforth, Quinlan and Ginis 2017; Webb, Joseph, Yardley 465 
and Michie 2010). One possible explanation for this, may be that brief information on 466 
vaccination is preferable. Shorter, more concise material may increase engagement, and 467 
therefore may be more effective in increasing risk appraisal. 468 
Meta regression analysis also showed that there was a difference in the effect of 469 
interventions delivered by people, compared to those delivered digitally or using printed 470 
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material. Specifically, those delivered by people  had a negative effect on risk (whilst 471 
interventions delivered digitally or with printed materials had a positive effect). This may be 472 
explained in a number of ways; firstly, research suggests that risk information is often 473 
communicated less effectively when done so verbally. Furthermore, interventions delivered 474 
face-to-face may be more at risk of variation in the way they are delivered, compared to more 475 
standardised paper digital materials.  Finally, some medical professionals may demonstrate a 476 
preference to promote informed choices of individuals, thus tempering messages that actively 477 
promote vaccination uptake (French and Marteau 2007).  478 
 479 
Strengths and Weaknesses 480 
Review-level strengths include that the present review was conducted and reported in line 481 
with PRISMA guidelines, and the Meta-Analysis Reporting Methods (MARS). Stringent 482 
inclusion criteria ensured that only studies that could contribute to understanding about the 483 
impact of interventions on risk appraisal on vaccination intention or uptake were included. 484 
This however also introduced a weakness in the ability of the review to draw conclusions, in 485 
that few studies met the inclusion criteria and could therefore be included in the review. This 486 
indicates the paucity of experimental studies that exist in this field and the need for more to 487 
further increase knowledge in this area. Grey literature was searched for and included, so 488 
authors are confident that all appropriate studies were found and included in the review. 489 
However, due to limited resources, only studies in the English language were included in the 490 
review. This may have excluded other potentially useful contributions to the topic. 491 
  492 
A strength of the present systematic review is the thorough risk of bias assessment it 493 
was subject to, using the Cochrane Risk of Bias Assessment Tool, which identified the 494 
frequent unclear reporting leading to unclear risk of bias assessments. 495 
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 496 
Study-level weaknesses include that the majority of studies were conducted in the 497 
United States. International differences in healthcare systems and vaccination programmes 498 
may mean that studies conducted in the United States may not be generalisable to populations 499 
within the United Kingdom or other European countries, nor to low-middle income countries. 500 
A further weakness lies with the failure of most studies to measure vaccination behaviour, 501 
with studies largely measuring intention to vaccinate instead.  502 
 503 
The illness being vaccinated against varied greatly amongst studies in this review. 504 
There is the potential that differences in appraisals of risk may exist between illnesses, 505 
meaning that the effect of risk on vaccination differs accordingly. For example, appraisals of 506 
Hepatitis B risk may be higher than for influenza risk due to the belief that the former causes 507 
serious liver damage, whereas the latter has few serious consequences. This means it is 508 
potentially problematic to directly compare interventions, as different risk appraisal processes 509 
may be present. Equally, how common an illness is may influence the success of the 510 
intervention, as less common illnesses may be perceived as more threatening and associated 511 
with higher appraisals of risk. Additionally, some illnesses examined in the included studies 512 
required one dose of vaccine (such as flu), whereas for other illnesses (such as HPV), 513 
required up to three doses. These behaviours are not directly comparable, with the latter being 514 
more difficult to perform. There were too few studies in the present review to compare the 515 
effect of risk appraisal on vaccination behaviour according to illness type or frequency of 516 
doses. Meta regression was often not possible due to there being insufficient studies in each 517 
sub-group, again highlighting the need for additional experimental studies in this field. 518 
 519 
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One strength of the included studies themselves was the use of composite measures of 520 
risk rather than single measures of risk, which was coded in 12 of the 18 included studies. 521 
Risk is a complex construct, which is better measured using composite measures due to the 522 
increased validity of multiple measures (Van Der Velde et al, 1996).  523 
 524 
A further strength of the included studies, is the study setting. Of the 18 included 525 
studies, 17 were conducted in a community rather than a laboratory setting. This is 526 
advantageous as it reduces the chance of bias as a result of artificial settings, and reflects real 527 
behavioural decisions, rather than a hypothetical decision.  528 
 529 
The present review highlighted a number of weaknesses in the existing literature on 530 
risk appraisal and vaccination uptake. First, the majority of included studies were rated as 531 
demonstrating an overall high risk of bias, largely attributable to the fact that a large 532 
proportion of domains across all studies were rated as ‘unclear’. A rating of unclear reflects 533 
limitations in the reporting of the study rather than necessarily being a weakness in 534 
methodology. However, a high risk of bias suggests that it is unclear whether results of the 535 
study reflect a true effect of the intervention and therefore a degree of caution should be 536 
employed when interpreting the results. The presence of high risk of bias ratings reduces 537 
confidence in the findings, and makes it difficult to conclude whether interventions that 538 
include risk messages are indeed successful in increasing risk appraisal or the uptake of 539 
vaccination. Once again, this leads to calls for  better conducted and reported studies on this 540 
topic.  541 
 542 
Second, it should be noted that in a number of the included studies, a similar level of 543 
intervention content was delivered in the control groups, as in the intervention groups. One 544 
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explanation for this may be that detailed intervention descriptions were often unavailable in 545 
the papers and contact with authors for further details was met with limited response. 546 
Therefore, BCT coding was often only possible on the information within the paper itself, 547 
and it is acknowledged that full interventions may have included more BCTs in their entirety.  548 
 549 
The BCT ‘Information about Health Consequences’ was coded within the control 550 
group of six included studies. Whilst only BCTs unique to the intervention group were 551 
included when examining the moderating effect of BCTs, the presence of BCTs within 552 
control groups that would be expected to have an impact of risk appraisal means that the 553 
relationship between risk and vaccination behaviour may be underestimated by our analysis. 554 
It is also important to examine the dose of BCTs in both the intervention and the control 555 
groups, as although a BCT may be present in both (and therefore not coded as a BCT unique 556 
to the intervention condition), it may appear more frequently, or may be a stronger influence 557 
in the intervention condition, than in the control condition (this can be seen in the practical 558 
application table, in Supplemental material 2 where BCT and dose of both intervention and 559 
control condition are detailed for each included study). This is supported by previous findings 560 
that intervention effects can be reduced in situations where the level of care received by the 561 
control group is higher (de Bruin, Viechtbauer, Schaalma, Kok, Abraham & Hospers, 2010).  562 
Furthrmore, only including those BCTs that are unique to the intervention group, may mean 563 
that clusters of BCTs working together to change behaviour may be ignored. 564 
 565 
It is important to consider that the primary aim of the included studies was often not 566 
to examine the effectiveness of an intervention involving a risk message, and so the 567 
interventions were often not specifically aiming to increase risk appraisal alone. The decision 568 
to include all interventions that targeted risk, regardless of whether they also targeted a 569 
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change in other variables, means that the effect of interventions on intentions and behaviour 570 
is confounded. The overall number of studies included in the review was too small to enable 571 
a number of planed analyses to be performed and therefore requiring included studies to only 572 
be examining risk appraisal would have reduced the pool further. Consequently, there is a 573 
need for more studies which aim to manipulate risk and efficacy exclusively (ideally with 574 
factorial design so that the independent and interaction effects of each can be examined). 575 
Also, the studies often tested methods of delivery, for example examining the effect of gain 576 
versus loss framing of risk information. Increases in risk appraisal found in included studies 577 
may therefore be attributable to other factors that are unrelated to the content of the 578 
intervention. 579 
 580 
Finally, limitations exist relating to how risk was measured. For example not all 581 
included studies measured levels of risk pre-intervention. This makes it unclear whether 582 
differences in risk between conditions existed at baseline, thus influencing differences 583 
between conditions post-interventions. Furthermore, the majority of studies included in this 584 
review measured risk using unconditional risk questions. To correctly assess appraisals of 585 
risk, participants should be asked about how likely they are to become ill if they don’t have 586 
the vaccination. By asking unconditional questions, participants may be taking into account 587 
their good intention. In this situation, risk appraisals are based on the perceived likelihood of 588 
becoming ill after having the vaccination, rather than the likelihood of becoming ill without it 589 
(Weinstein et al 1998). This makes it difficult to draw firm conclusions about the influence 590 
that risk messages have on risk appraisal and vaccination uptake. Finally, the way risk was 591 
measured varied greatly between studies, with some measuring risk in terms of likelihood, 592 
some measuring severity and some measuring both likelihood and severity. It is 593 
acknowledged that these ways of measuring risk are theoretically different and depending on 594 
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the measurement choices made may have impacted upon the ability of studies to capture any 595 
intervention effects.   596 
 597 
What This Study Adds 598 
This is the first systematic review to examine the effect of interventions on risk 599 
appraisal and vaccination intentions or uptake using only experimental studies. It builds on a 600 
previous meta-analysis in this area (Brewer et al, 2007) which included not only experimental 601 
studies, but also prospective and cross-sectional studies. Including only experimental studies 602 
is important because it increases the strength of conclusions which can be drawn about the 603 
effect of interventions on risk and behaviour.  The findings of this review are however 604 
inconclusive. The lack of unique BCT content within intervention conditions, along with the 605 
high risk of bias and almost total reliance on unconditional measures of risk by studies 606 
examining those interventions, means that we cannot be confident in the findings. 607 
Consequently the potential value of this type of review in better understanding how to 608 
increase risk in order to increase vaccination behaviour is lost. Instead its value is in shining a 609 
light on the paucity of experimental studies in this area, and the quality of methods and 610 
reporting used. It should be noted that eight of the 18 included studies were conducted in the 611 
past five years. This is encouraging as it indicates increasing use of experimental designs.  612 
  613 
A secondary aim of the present review was to examine the relationship between risk 614 
and vaccination intention and uptake. Earlier work by Sheeran and colleagues found that risk 615 
appraisal had a small but significant effect on vaccination intention (d= 0.38) and behaviour 616 
(d= 0.33). Whilst the review by Sheeran and colleagues only included studies that had a 617 
significant effect on susceptibility or severity in order to enable this relationship to be 618 
observed (pooled effects being d= 0.75 and d= 0.56 respectively), the inclusion of all studies 619 
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in the present review regardless of their success in changing risk appraisal reduced the size of 620 
the overall effect. Given the small pooled effect on risk appraisal, the possible reasons for 621 
which have been discussed above, it is unsurprising then that no relationship between risk 622 
and vaccination intentions or uptake was observed. The present review is therefore unable to 623 
contribute new knowledge about the relationship between risk and vaccination intentions or 624 
uptake.     625 
 626 
This systematic review builds on work conducted by Sheeran, Harris and Epton 627 
(2014) as it adds to evidence more broadly about the relationship between risk appraisal and 628 
behaviour. The current review included studies that would have been omitted by Sheeran and 629 
colleagues which only included RCTs that were successful in changing risk appraisals. 630 
Restricting studies to those examining single health behaviour controls for factors relating to 631 
the nature of the behaviour itself which may confound results.   632 
 633 
Implications for Practice 634 
The present review demonstrates that interventions in included studies utilise relatively few 635 
BCTs. For this reason, specific recommendations regarding which BCTs should be included 636 
in interventions to successfully increase vaccination intention or uptake cannot be made. 637 
There is compelling evidence that providing information about the risk of health, or the risk 638 
of failing to carry out the health behaviour alone is not sufficient to elicit behaviour change 639 
(French, Cameron, Benton, Deaton & Harvie, 2017). Additional BCTs may improve the 640 
effectiveness of interventions in increasing risk appraisal and subsequent uptake of 641 
vaccination.   642 
 643 
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Recent research suggests that simultaneously increasing efficacy appraisals with risk 644 
appraisals is an important parameter for having an overall effect on behaviour. Evidence 645 
suggests that the effect of increasing risk appraisal on intention or behaviour is further 646 
increased when efficacy appraisals are also high (Kok, Gottlieb, Peters, Mullen, Parcel, 647 
Ruiter et al, 2015; Sheeran et al, 2014). Unfortunately, because only three studies within this 648 
review significantly increased efficacy appraisals, conclusions could not be drawn about the 649 
interaction between risk appraisals and efficacy appraisals. This highlights the need for future 650 
research to examine the effect of increasing both risk and efficacy appraisals, ideally using 651 
full factorial designs that enable individual and interaction effects to be observed.  In the 652 
meantime,   interventions should aim to target an increase in self-efficacy and response 653 
efficacy simultaneously with risk appraisal in order to prevent defensive processing. The 654 
present review found that interventions delivered by people, as opposed to those delivered 655 
digitally or via printed materials, were less effective at increasing risk appraisals. This maybe 656 
because risk information communicated verbally is more difficult to absorb and understand. 657 
This concurs with other work which has found that interventions utilising images or visual 658 
components have been found to be successful predictors of changing risk appraisal (French, 659 
Cameron, Benton, Deaton & Harvie, 2017). Accordingly it is advised that future 660 
interventions aiming to communicate risk incorporate images into their design. .  661 
 662 
Implications for Research 663 
The present review highlights the need for robust, well reported experimental studies 664 
examining the effect of interventions on risk and vaccination behaviour. Reporting of 665 
methods by included studies was often vague and incomplete, and future studies would 666 
benefit from clearer more transparent reporting. As previously highlighted, the reporting of 667 
methods and intervention content by authors is currently inadequate. This makes assessing 668 
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the quality of experimental studies, their risk of bias, and accurately coding the presence of 669 
BCTs difficult. We acknowledge that journal restrictions may prevent detailed reporting of 670 
intervention content within the paper itself. As an alternative, we urge authors to use 671 
supplementary files where permitted, publish intervention content separately, or to make 672 
content descriptions available via the web. 673 
 674 
Risk of bias assessment revealed that the main potential source of bias was ‘Random 675 
Sequence Generation’ and of the 18 studies assessed, eight were allocated an unclear rating, 676 
and three a high rating. In addition to this, 13 studies were allocated an unclear rating for 677 
‘Selective Reporting’, reflecting a need for better reporting.  678 
 679 
Future research would benefit from exploring potential reasons why interventions 680 
using digital or printed methods may be more effective in increasing risk appraisals, than 681 
those delivered fact-to-face. This may include difficulties communicating risk verbally, and 682 
the reluctance of medical professionals to actively recommend vaccination. Furthermore, it 683 
would be beneficial for future research to explore whether briefer interventions are more 684 
successful in increasing risk appraisal than longer, more in-depth interventions. 685 
 686 
Conclusion 687 
This systematic review is the first to explore the influence that interventions containing risk 688 
messages have on risk appraisal and vaccination intention and uptake using only 689 
experimental studies. Weaknesses in the included studies mean that it is not possible to draw 690 
firm conclusions about effect of interventions on risk, nor to examine the relationship 691 
between risk appraisal and vaccination behaviour. Successful interventions might benefit 692 
29 
Risk Messages on Vaccination and Risk Appraisal 
 
 
from using more BCTs, and from targeting increases in self-efficacy and response efficacy, in 693 
addition to risk appraisal. 694 
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Figure 1:  897 
Flowchart of included studies 898 
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Table 1:  
Summary table of frequency of characteristics of included studies 
Characteristic  Number of studies 
Study Country 
 
US 
Other (non US 
country) 
11 
7 
Illness being 
vaccinated against 
 
Flu 
HPV 
Hepatitis B 
Flu and 
pneumococcal 
Tetanus 
8 
6 
2 
1 
 
1 
Participants pregnant 
or not 
Pregnant 
Not pregnant 
5 
13 
Measure of risk Composite 
Single 
12 
6 
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Table 2:  
Effects of risk appraisals, intention and behaviours, according to potential moderators. 
 
Outcome 
variable 
Moderator Sub group Number 
of 
studies/ 
total 
sample 
size 
d ∆d Q Standard 
error 
Confidence 
intervals 
(95%) 
Reference 
Group 
Number of 
studies/ 
total 
sample 
size (of 
reference 
group) 
d (of 
reference 
group) 
Risk            
 Efficacy 
Appraisal also 
increased 
Increased 3/449 0.372 0.242 0.92 0.253 (-0.254, 
0.738) 
Not increased  14/6584 0.130 
Type of risk 
question used 
Conditional 
question 
4/1083 0.019 -0.218 1.61 0.172 (-0.554, 
0.119) 
Unconditional 
question 
12/5950 0.237 
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Outcome 
variable 
Moderator Sub group Number 
of 
studies/ 
total 
sample 
size 
d ∆d Q Standard 
error 
Confidence 
intervals 
(95%) 
Reference 
Group 
Number of 
studies/ 
total 
sample 
size (of 
reference 
group) 
d (of 
reference 
group) 
Illness type Flu 9/5023 0.228 -0.122 0.57 0.162 (-0.439, 
0.196) 
Other  8/2125 0.106 
HPV 3/1490 0.049 0.139 0.45 0.207 (-0.207, 
0.545) 
Other 13/5543 0.188 
Age Group Adult 10/2105 0.250 -0.239 1.92 0.174 (-0.577, 
0.099) 
Other 6/4928 0.011 
Older adult 5/4177 -0.000 0.245 1.94 0.175 (-0.099, 
0.589) 
Other 11/2856 0.244 
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Outcome 
variable 
Moderator Sub group Number 
of 
studies/ 
total 
sample 
size 
d ∆d Q Standard 
error 
Confidence 
intervals 
(95%) 
Reference 
Group 
Number of 
studies/ 
total 
sample 
size (of 
reference 
group) 
d (of 
reference 
group) 
Pregnancy Pregnant 3/645 0.396 0.269 1.19 0.247 (-0.215, 
0.752) 
Not pregnant 13/6395 0.127 
BCT 
Information 
about Health 
Consequences 
Included 6/3449 0.033 -0.238 2.02 0.168 (-0.567, 
0.090) 
Not included 10/3584 0.271 
BCT 
Information 
Included 3/694 -0.179 -0.431* 4.58 0.201 (-0.826,- 
0.036) 
Not included 13/6339 0.252 
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Outcome 
variable 
Moderator Sub group Number 
of 
studies/ 
total 
sample 
size 
d ∆d Q Standard 
error 
Confidence 
intervals 
(95%) 
Reference 
Group 
Number of 
studies/ 
total 
sample 
size (of 
reference 
group) 
d (of 
reference 
group) 
about Social 
and 
Environmental 
Consequences 
BCT Credible 
Source 
Included 2/561 0.005        
Not included 14/6472 0.204        
Number of 
BCTs used 
Less than 
two 
10/5137 0.344 -0.431** 8.25 0.150 (-0.726, -
0.137) 
Two or more 6/1896 -0.088 
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Outcome 
variable 
Moderator Sub group Number 
of 
studies/ 
total 
sample 
size 
d ∆d Q Standard 
error 
Confidence 
intervals 
(95%) 
Reference 
Group 
Number of 
studies/ 
total 
sample 
size (of 
reference 
group) 
d (of 
reference 
group) 
           
Mode of 
Delivery 
Digital 8/5123 0.243 -0.201 1.54 0.162 (-0.517, 
0.116) 
Other 8/1910 0.042 
Human 3/956 -0.252 -0.514** 7.21 0.191 (0.139, 
0.890) 
Other 13/6077 0.262 
Printed 
Materials 
5/954 0.319 -0.201 0.98 0.203 (0.560, 
0.198) 
Other 11/6079 0.118 
Intention            
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Outcome 
variable 
Moderator Sub group Number 
of 
studies/ 
total 
sample 
size 
d ∆d Q Standard 
error 
Confidence 
intervals 
(95%) 
Reference 
Group 
Number of 
studies/ 
total 
sample 
size (of 
reference 
group) 
d (of 
reference 
group) 
 Illness Type Flu 8/4602 0.152 0.034 0.02 0.220 (-0.396, 
0.465) 
Other 4/520 0.117 
Age Group Adults 8/1366 0.112 0.078 0.10 0.246 (-0.404, 
0.559) 
Other 4/3909 0.190 
Pregnancy Pregnant 3/645 0.045 -0.110 0.14 0.289 (-0.675, 
0.456) 
Not pregnant 9/4630 0.155 
BCT 
Information 
Included 4/3047 0.128 -0.007 0.00 0.247 (-0.491, 
0.477) 
Not included 8/2228 0.135 
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Outcome 
variable 
Moderator Sub group Number 
of 
studies/ 
total 
sample 
size 
d ∆d Q Standard 
error 
Confidence 
intervals 
(95%) 
Reference 
Group 
Number of 
studies/ 
total 
sample 
size (of 
reference 
group) 
d (of 
reference 
group) 
about Health 
Consequences 
BCT Credible 
Source 
Included 1/158 0.062        
Not included 11/5117 0.140        
Number of 
BCTs used 
Less than 
two 
10/4984 0.103        
Two or more 2/291 0.372        
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Outcome 
variable 
Moderator Sub group Number 
of 
studies/ 
total 
sample 
size 
d ∆d Q Standard 
error 
Confidence 
intervals 
(95%) 
Reference 
Group 
Number of 
studies/ 
total 
sample 
size (of 
reference 
group) 
d (of 
reference 
group) 
Mode of 
Delivery 
Digital 6/4384 0.126 0.052 0.01 0.230 (-0.426, 
0.476) 
Other 6/684 0.151 
Behaviour            
 Illness Type Flu 1/115 0.375        
HPV 3/1490 -0.333        
Pneumonia 1/115 2.000        
 Age Group Adolescent 1/751 -0.045        
 Adult 2/739 -0.482        
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Outcome 
variable 
Moderator Sub group Number 
of 
studies/ 
total 
sample 
size 
d ∆d Q Standard 
error 
Confidence 
intervals 
(95%) 
Reference 
Group 
Number of 
studies/ 
total 
sample 
size (of 
reference 
group) 
d (of 
reference 
group) 
 Older adult 1/115 0.871        
 BCT 
Information 
about Health 
Consequences 
Included 3/1116 0.081        
 Not included 1/489 -0.033        
 BCT Credible 
Source 
Included 2/1001 -0.471        
 Not included 2/604 0.605        
 Included 2/604 0.605        
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Outcome 
variable 
Moderator Sub group Number 
of 
studies/ 
total 
sample 
size 
d ∆d Q Standard 
error 
Confidence 
intervals 
(95%) 
Reference 
Group 
Number of 
studies/ 
total 
sample 
size (of 
reference 
group) 
d (of 
reference 
group) 
 BCT 
Information 
about Social 
and 
Environmental 
Consequences 
Not included 2/1001 -0.471        
 Mode of 
Delivery 
Digital 2/1200 -0.487        
 Human 2/866 0.589        
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Notes: Blank cells indicate that there was insufficient variability in the moderator to conduct the analysis (less than three studies). 
*p<.05; **p<.01; ***p<.001 
 
